Nizar Souayah, MD, FAAN, FAANEM, FANA, explains the role of repetitive nerve stimulation and single-fiber EMG in diagnosing MG. He highlights why single-fiber EMG is the most sensitive test, particularly when antibody testing is negative, or symptoms are mild or ocular.
What is the role of repetitive nerve stimulation versus single-fiber electromyography?
Transcript
Repetitive nerve stimulation is a specific diagnosis for myasthenia gravis, but its sensitivity is limited. In generalized disease, it detects around 70 to 80% of cases, but in ocular or mild disease it drops to 30 to 50%.
A normal study does not rule out the diagnosis of myasthenia gravis.
Single-fiber EMG is the most sensitive test we have right now, exceeding 90% even in purely ocular disease. It measures the jitter at the neuromuscular junction and detects transmission failure that repetitive nerve stimulation does miss.
In practice, if the patient has clear generalized weakness and positive antibody testing, repetitive nerve stimulation is often sufficient. But if you suspect, if I suspect ocular disease, if antibodies are negative, or if the clinical picture is ambiguous, I go directly to single-fiber EMG.
One practical barrier I want to acknowledge. Well, to be honest with that, single-fiber EMG requires specialized training and is not available in every community lab.
If it’s not available locally, you better refer the patient to a center that can do it rather than relying on a negative repetitive nerve stimulation and close your case.
The take-home message is that repetitive nerve stimulation confirms when positive, but when clinical suspicion is high and initial repetitive nerve stimulation is negative or inconclusive, single-fiber EMG is the test you need always to prioritize.
You have to prioritize sensitivity over convenience.